Prefilled Syringes Market: Trends & Forecasts
- The global prefilled syringes market is experiencing meaningful growth,fueled by an increasing prevalence of chronic diseases and advancements in self-injection technologies.
- growing awareness among both patients and healthcare professionals regarding the benefits of prefilled syringes, coupled with the rising number of biologics and biosimilars in the pharmaceutical sector, further...
- A Geneva Association report indicates that global healthcare expenditure has risen from approximately 8% to nearly 10% of GDP in the last two decades, reaching an estimated $8...
The prefilled syringes market is booming, fueled by rising chronic disease prevalence, advancements in self-injection technology, and supportive regulations. This growth is further propelled by increased awareness among patients and healthcare providers, along with a surge in biologics and biosimilars. Europe currently leads in revenue, yet the Asia-Pacific region is set to become the largest market, driven by healthcare investments and advanced drug delivery system demands. Conventional prefilled syringes dominate, offering safety and ease of use, while plastic options are rapidly growing thanks to innovative polymers. News Directory 3 provides insights into the key players. Discover what’s next for this dynamic market.
prefilled Syringes Market Driven by Chronic Diseases and Self-Injection Advancements
Updated June 02,2025
The global prefilled syringes market is experiencing meaningful growth,fueled by an increasing prevalence of chronic diseases and advancements in self-injection technologies. Supportive goverment regulations, particularly those addressing needlestick injuries, also contribute to this expansion.
growing awareness among both patients and healthcare professionals regarding the benefits of prefilled syringes, coupled with the rising number of biologics and biosimilars in the pharmaceutical sector, further supports market growth. However, insufficient healthcare funding in emerging markets continues to pose challenges.
A Geneva Association report indicates that global healthcare expenditure has risen from approximately 8% to nearly 10% of GDP in the last two decades, reaching an estimated $8 trillion annually. The Global Burden of Disease Health Financing Collaborator Network projects this spending could nearly triple to $24 trillion by 2040, with upper-middle-income countries showing the fastest growth.
Europe is a major revenue-generating region, driven by chronic disease prevalence, biologics market growth, technological advancements, and the increasing adoption of self-injection devices. The prefilled syringes market is also seeing increased demand due to an aging population.
The conventional prefilled syringes market currently holds the largest share, attributed to their safe governance, ease of use, reduced contamination risk, and improved dosing accuracy. Plastic prefilled syringes are projected to be the fastest-growing segment, thanks to the development of new polymers with enhanced properties.
Gerresheimer, a key player in the prefilled syringes market, held a 13.3% market share in 2019. The company focuses on product launches and partnerships to maintain its position, serving major pharmaceutical and healthcare companies.
What’s next
The Asia-Pacific region is poised to emerge as the largest market for prefilled syringes, driven by increasing healthcare investments and growing demand for advanced drug delivery systems.